BryceTech has secured three multi-year prime contracts from the Defense Department worth about $70 million over five years to support the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
The awards position BryceTech to deliver acquisition, scientific, technical and programmatic expertise as part of a 50-person team. The work will accelerate medical countermeasure development, bolster decision-support systems and improve operational coordination across research, logistics, quality assurance and program execution.
The contracts back three key offices:
-
JPL Enabling Biotechnologies: Advances development, manufacturing, testing and deployment of medical countermeasures.
-
JPM CBRN Integration: Provides CBRN threat warning, hazard prediction and decision-support systems.
-
JPM CBRN Medical: Fields FDA-approved diagnostics, therapeutics and vaccines against evolving threats.
The work was awarded under the General Services Administration’s OASIS+ vehicle and ensures continuity of services for critical national security missions.
“Protecting the Joint Warfighter depends on advancing and integrating CBRN defense capabilities that allow our forces to operate, fight, and win,” said Jeff Mujsce, chief growth officer at BryceTech. “These three offices are central to developing, sustaining, and improving those capabilities. BryceTech is proud to provide the dedicated, highly qualified staff needed to strengthen programs, enhance integration, and deliver results where they matter most.”